Literature DB >> 23242724

Gene networks implicated in diabetic kidney disease.

W Tang1, Y Gao, Y Li, G Shi.   

Abstract

BACKGROUND: Diabetic kidney disease (DKD) is one of the main causes of renal end-stage disease. The incidence of DKD has increased substantially over the past few years. However, our understanding to the molecular mechanism of DKD is still essential, and an effective treatment has not been developed. AIM: We aimed to explore the molecule mechanism in the development of DKD, and provide a comparison of DKD in different compartments.
MATERIALS AND METHODS: In this study, we implemented a system biology approach and analyzed gene expression profiles in 22 microdissected human renal glomerular and 22 tubule samples from healthy patients and patients with DKD.
RESULTS: The WGCNA (Weighted Gene Co-expression Network Analysis) analysis identified 10 modules of genes with high topological overlap in tubuli and 12 modules in glomeruli. Several TFs (transcription factors) were found expressed in both compartments, such as ETS1, ETV4, JUN, LITAF, NFE2, RARG and STAT5A. These genes may be used as therapeutic targets for DKD. By comparing the modules in the two compartments, we found that dysregulation of cell proliferation may significantly contribute to the development of DKD. Furthermore, our results concluded that DKD may be an immune-mediated degenerative disease.
CONCLUSIONS: Our studies identified multiple genes that may play an important role in the pathogenesis of DKD and provided a system understanding of the potential relationships among these genes. We hope our study could aid in understanding of DKD and could provide the basis for DKD biomarker discovery.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23242724

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Make Precision Medicine Work for Chronic Kidney Disease.

Authors:  Ling Sun; Lu-Xi Zou; Mao-Jie Chen
Journal:  Med Princ Pract       Date:  2016-12-14       Impact factor: 1.927

Review 2.  Glycemic memories and the epigenetic component of diabetic nephropathy.

Authors:  Samuel T Keating; Assam El-Osta
Journal:  Curr Diab Rep       Date:  2013-08       Impact factor: 4.810

3.  Urinary sediment CCL5 messenger RNA as a potential prognostic biomarker of diabetic nephropathy.

Authors:  Song-Tao Feng; Yang Yang; Jin-Fei Yang; Yue-Ming Gao; Jing-Yuan Cao; Zuo-Lin Li; Tao-Tao Tang; Lin-Li Lv; Bin Wang; Yi Wen; Lin Sun; Guo-Lan Xing; Bi-Cheng Liu
Journal:  Clin Kidney J       Date:  2021-09-28

4.  Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.

Authors:  Chengji Cui; Yabin Cui; Yanyan Fu; Sichao Ma; Shoulin Zhang
Journal:  Mol Med Rep       Date:  2017-11-28       Impact factor: 2.952

5.  ERK and p38 MAPK inhibition controls NF-E2 degradation and profibrotic signaling in renal proximal tubule cells.

Authors:  Jia Li; Shunying Jin; Michelle T Barati; Sanjana Rane; Qian Lin; Yi Tan; Lu Cai; Madhavi J Rane
Journal:  Life Sci       Date:  2021-10-29       Impact factor: 5.037

6.  Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.

Authors:  Yumin Zhang; Wei Li; Yunting Zhou
Journal:  Ann Transl Med       Date:  2020-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.